These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 5125156
1. [Mechanism of action of new sympathomimetics (dopamine and wyamine) and the ir therapeutic possibilities in cardiogenic shock]. Döring D. Z Gesamte Inn Med; 1971 Jul 01; 26(13):Suppl:170-2. PubMed ID: 5125156 [No Abstract] [Full Text] [Related]
2. Evaluation of the pharmacologic basis for the therapy of circulatory shock. Moran NC. Am J Cardiol; 1970 Dec 01; 26(6):570-7. PubMed ID: 4398718 [No Abstract] [Full Text] [Related]
3. Indications for adrenergic stimulators in shock. Mills LC, Moyer JH. Int Z Klin Pharmakol Ther Toxikol; 1971 Jun 01; 4(4):385-95. PubMed ID: 5566718 [No Abstract] [Full Text] [Related]
7. Effects of 2-[(5-chloro-2-methoxyphenyl)azo]-1H-imidazole (M6434) on hemorrhagic, cardiogenic, and endotoxin shock in rats and rabbits. Ohnishi H, Yamaguchi K, Sato M, Uemura A, Funato H, Dabasaki T. Circ Shock; 1984 Apr 25; 13(3):261-70. PubMed ID: 6467523 [Abstract] [Full Text] [Related]
8. Use of sympathomimetic amines in shock. Goldberg LI. Am Fam Physician; 1974 Jul 25; 10(1):80-5. PubMed ID: 4152035 [No Abstract] [Full Text] [Related]
9. Pharmacology of pressor agents on the systemic circulation. Ahlquist RP. Semin Drug Treat; 1973 Jul 25; 3(3):231-40. PubMed ID: 4360321 [No Abstract] [Full Text] [Related]
10. [Influencing of the kidney function by new sympathomimetics]. Lieschke HJ. Z Gesamte Inn Med; 1971 Jul 01; 26(13):Suppl:175-6 c. PubMed ID: 5125157 [No Abstract] [Full Text] [Related]
11. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs]. Urbaszek W, Günther K, Trenckmann H, Döring D. Z Gesamte Inn Med; 1970 Apr 01; 25(7):290-3. PubMed ID: 4398843 [No Abstract] [Full Text] [Related]
13. [The use of dopamin in shock and heart failure (author's transl)]. Aroński A, Kübler A, Sliwinski M, Paszkowska A. Anaesthesist; 1978 Apr 01; 27(4):183-6. PubMed ID: 655365 [Abstract] [Full Text] [Related]
14. [Clinical use of a new sympathomimetic amine, dimethoprine]. Arcidiacono R, Sanna GP. Minerva Cardioangiol; 1972 Sep 01; 20(9):526-35. PubMed ID: 5071473 [No Abstract] [Full Text] [Related]
15. Dopamine--clinical uses of an endogenous catecholamine. Goldberg LI. N Engl J Med; 1974 Oct 03; 291(14):707-10. PubMed ID: 4604342 [No Abstract] [Full Text] [Related]
17. Dopamine for cardiogenic shock. Karliner JS. JAMA; 1973 Dec 03; 226(10):1217-8. PubMed ID: 4800497 [No Abstract] [Full Text] [Related]
18. [Dopamine and shock. Preliminary clinical study of 7 cases]. Dubouloz F, Martin C, Fogliani J, Nava G. Ann Anesthesiol Fr; 1975 Dec 03; 16(9):701-3. PubMed ID: 5033 [Abstract] [Full Text] [Related]
19. Dopamine and other vaso-active agents in shock (edited summary). Thompson WL. Scott Med J; 1979 Jan 03; 24(1):89-93. PubMed ID: 493938 [No Abstract] [Full Text] [Related]
20. [Controlled polycentric clinical study of a new sympathomimetic preparation: dimethophrine]. Portioli I, Rocchi F, Bianchi G, Bianchini E, Dotti F, Lotto A, Bossi M, Uleri G, Zuccoli P, Ferrari M, Bigi N, Andreoli L, Tolva D, Anversa A, Volta G. Clin Ter; 1971 Sep 30; 58(6):495-547. PubMed ID: 5156951 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]